ArticlePigment cell & melanoma research2020

RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy.

Mona Foth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.